维普中文期刊产品整合服务
22篇 您的检索式:作者名="Dahlen T"
    题名 作者 年代 出处 被引量
1Large vestibular aqueduct syndrome:a genetic disease?显示文摘TONG K A HARNSBERGER H R DAHLEN R T 1997AJR Am J Roentgenol1997,168,4:1
2CoppeR deficiency increases fibulin-5 but decreases cytochrome C oxidase VIb subunit expression in rat heart显示文摘Zeng H Saari J T Dahlen G M 2006J lnorg Biochem2006,100,2:1
3High levels of urinary leukotriene E4 excretion in steroid treated patients with severe asthma 显示文摘Vachier I Kumlin M Dahlen SE Bousquet T Godard P Chanez P 2003Respir Med2003,97,11:1
42,5 - Dimethyl-4- hydroxy -3 (2H)--Furanone as a Secondary Metabolite from D-Fructose- 1,6-Diphosphate Metabolism by Zygosaccharomyces rouxii 显示文摘Dahlen T Hauck T Wein M 2001Journal of Bioscience and Bioengineering2001,91,4:1
5Characterization of Bacteroides forsythus isolates显示文摘Takemoto T Kurihara H Dahlen G 1997J Clin Microbiol1997,35,:1
6Microbiological evaluation ofone-and two-visit endodontic treatment of teeth with apical peri-odontitis:a randomized,clinical trial显示文摘Kvist T Molander A Dahlen G 2004J Endod2004,30,8:1
7Overlapping thin section fast spin-echo MR of the large vestibular aqueduct syndrome显示文摘Dahlen R T Harsberger H R Gray S D 1997AJNR1997,18,1:1
8Characterization of Bacteroides forsythus isolates显示文摘Takemoto T Kurihara H Dahlen G 1997J Clin Microbiol1997,35,:1
9Carotid inti- ma-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle-aged patients with Type 2 diabetes 显示文摘DAHLEN E M LANNE T ENGVALL J 2009Diabetic Medicine2009,26,4:1
10CT and MR imaging characteristics of intravestibular lipoma 显示文摘Dahlen R T Johnson C E Harnsberger H R 2002AJNR2002,23,8:1
11Dislocation fractures in the area of the middle foot:Injuries of the Chopart and Lisfranc joint显示文摘Randt T Dahlen C Schikore H 1998Zentralbl Chir1998,,123:1
12Overlapping thin-section fast spin-echo MR of the large vestibular aqueduct syndrome显示文摘Dahlen R T Harnsberger H R Gray S D 1997AJNR1997,18,2:1
13Carotid intima-media thickness and apolipoprotein B/apolipoprotein A-I ratio in middle-aged patients with Type 2 diabetes显示文摘Dahlen E M Lanne T Engvall J 2009Diabetic Medicine2009,26,4:1
14Microbiological evaluation of one-and two-visit endodontic treatment of teeth with apical periodontitis:a randomized,clinical trial显示文摘Kvist T Molander A Dahlen G 2004J Endod2004,30,8:1
15Abdominal obesity and low-grade systemic inflammation as markers of subclinical organ damage in type 2 diabetes 显示文摘Dahlen EM Tengblad A Lanne T 2014Diabetes Metab2014,40,1:1
162, 5-Dimethyl-4-Hydroxy-3 (2H)-furanone as a secondary metabolite from D-fructose-1, 6-diphosphate metabolism by Zygosaccharomyces rouxii 显示文摘DAHLEN T HAUCK S WEIN M 2001J Biosci Bioeng2001,91,4:1
17Overlap- ping thin - section fast spin - echo MR of the large vestib- ular aqueduct syndrome 显示文摘Dahlen R T Hamsberger H R Gray S D 1997AJNR Am J Neuroradiol1997,18,1:1
18Apolipoprotein B100 is required for hepatitis C infectivity and Mipomersen inhibits hepatitis C显示文摘AIM To characterize the role of apolipoprotein B100(apoB 100) in hepatitis C viral(HCV) infection. METHODS In this study, we utilize a gene editing tool, transcription activator-like effector nucleases(TALENs), to generate human hepatoma cells with a stable genetic deletion of APOB to assess of apoB in HCV. Using infectious cell culture-competent HCV, viral pseudoparticles, replicon models, and lipidomic analysis we determined the contribution of apoB to each step of the viral lifecycle. We further studied the effect of mipomersen, an FDAapproved antisense inhibitor of apoB 100, on HCV using in vitro cell-culture competent HCV and determined itsimpact on viral infectivity with the TCID50 method. RESULTS We found that apo B100 is indispensable for HCV infection. Using the JFH-1 fully infectious cell-culture competent virus in Huh 7 hepatoma cells with TALENmediated gene deletion of apoB(APOB KO), we found a significant reduction in HCV RNA and protein levels following infection. Pseudoparticle and replicon models demonstrated that apo B did not play a role in HCV entry or replication. However, the virus produced by APOB KO cells had significantly diminished infectivity as measured by the TCID-50 method compared to wildtype virus. Lipidomic analysis demonstrated that these virions have a fundamentally altered lipidome, with complete depletion of cholesterol esters. We further demonstrate that inhibition of apoB using mipomersen, an FDA-approved anti-sense oligonucleotide, results in a potent anti-HCV effect and significantly reduces the infectivity of the virus. CONCLUSION Apo B is required for the generation of fully infectious HCV virions, and inhibition of apo B with mipomersen blocks HCV. Targeting lipid metabolic pathways to impair viral infectivity represents a novel host targeted strategy to inhibit HCV.Esperance AK Schaefer James Meixiong Christina Mark Amy Deik Daniel L Motola Dahlene Fusco Andrew Yang Cynthia Brisac Shadi Salloum Wenyu Lin Clary B Clish Lee F Peng Raymond T Chung 2016World Journal of Gastroenterology2016,22,45:1
192, 5-Dimethyl-4-hydroxy-3 (2H)-Furanone as a Secondary Metabolite from D-Fructose-1,6-Diphosphate Metabolism by Zygosaccharomyces rouxii 显示文摘DAHLEN T HAUCK T WEIN M 2001J Biosci Bioeng2001,91,4:1
20Large vestibularaqueduct syndrome:a genetic disease?显示文摘Tong K A Hamsberger H R Dahlen R T 1997AJR Am J Roentgenol1997,168,4:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费